AdaptHealth Company Overview

AdaptHealth Overview Leading Provider of HME, CGM / diabetes management products and medical supplies to the home National footprint with density in attractive geographies Serve ~2.8mm unique patients (1) Industry-leading technology platform Long-standing and diverse referral relationships and attractive payor mix Addressing large and growing market: Ticker Headquarters Outstanding Shares AHCO Plymouth Meeting, PA 147.4mm(4) Market Cap (12/31/20) $5,524mm HME: $12-$15bn segment in the broader $56bn HME industry(2) LTM 9/30 Net Revenue CGM & Diabetes (3): $16bn segment Medical Supplies to the Home (3): $10bn segment Successful track record of growth, accretive capital deployment, and market-leading profitability Targeting 8-10% annual organic growth (1) (2) adapthealth (3) (4) €2000 Pro forma for acquisition of AeroCare (5) (6) LTM 9/30 Adjusted EBITDA $1,679mm(5) $488mm(6) LTM 9/30 Adjusted EBITDA less Patient CapEx $339mm(6) Company analysis based on market and Wall Street research Target markets post-Solara and ActivStyle acquisitions from company analysis based on market and Wall Street research Represents shares outstanding on a pro forma basis including the AeroCare acquisition and the January 2021 equity offering Includes historical contribution of AeroCare, PCS and Solara acquisitions, but excludes certain closed acquisitions Pro forma as adjusted for closed acquisitions; includes $50mm of full run-rate synergies. Management expects to incur approximately $20 million in costs to achieve these synergies, which are expected to be fully realized by 2022 1

View entire presentation